Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The QSAR analysis has been performed according to the REACh Guidance on QSARs R.6, May/July 2008.

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: REACh Guidance on QSARs R.6, May/July 2008
Principles of method if other than guideline:
OECD Q(S)AR Toolbox prediction
GLP compliance:
not specified
Test type:
other: QSAR prediction
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
ethyl 2-(cyclopent-2-en-1-yl)acetate
EC Number:
605-150-6
Cas Number:
15848-49-4
Molecular formula:
C9H14O2
IUPAC Name:
ethyl 2-(cyclopent-2-en-1-yl)acetate
Details on test material:
SMILES:C1(CC(=O)OCC)=CCCC1

Test animals

Species:
other: Rat;Mouse;rat, Wistar (SPF);rabbit
Strain:
other: Sprague-Dawley;New Zealand White;Wistar

Administration / exposure

Route of administration:
oral: gavage

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 510 mg/kg bw

Any other information on results incl. tables






The prediction was based on dataset comprised from the following descriptors: LD50
Estimation method: Linear approximation
Model equation:
LD50 = -424 (±1429) +962 (±363) * log Kow, mg/kg bw
Domain logical expression:Result: In Domain

(("a" and "b" ) and ("c" and "d" ) )

Domain logical expression index: "a"

Referential boundary: The target chemical should be classified as Allyl AND Carboxylic acid ester AND Cycloalkene by Organic functional groups

Domain logical expression index: "b"

Referential boundary: The target chemical should be classified as High (Class III) by Toxic hazard classification by Cramer (with extensions)

Domain logical expression index: "c"

Parametric boundary:The target chemical should have a value of log Kow which is >= -1.09

Domain logical expression index: "d"

Parametric boundary:The target chemical should have a value of log Kow which is <= 6.43

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Based on the predicted oral LD50 of 2510 mg/kg bw, the substance is not classified (NC) according to the criteria of the Directive 67/548/EEC or EU CLP Regulation (EC) 1272/2008 for acute lethality.
Executive summary:

The categorization for the grouping of analogues has been based on Functional Groups similarity, and only molecules contanining allyl, carboxylic acid ester and cycloalkene feature were included.

After applying a trend analysis of the analogues, the categorization is refined by Cramer class category. The only chemicals removed being of lower toxicity class, this refinement is considered conservative.

In order to follow a worst case approach, the clear outliers to the curve are then manually discarded, which increases the slope.

Those refinements do not, however, have any dramatic impact on the predicted LD50, which always stays above 2500mg/kg bw.

Any attempt of further refinement (by test conditions or other profilers) of the category only leads to an increase of the value of the LD50.

Based on the predicted oral LD50 of 2510 mg/kg bw, the substance is not classified (NC) according to the criteria of the Directive 67/548/EEC or EU CLP Regulation (EC) 1272/2008 for acute lethality.